baber/WOPTO huggingface dataset:
Patent AU-2021337000-A1 (AU)
Title: Enhanced expansion and cytotoxicity of engineered natural killer cells and uses thereof
Inventor: TRAGER JAMES
IPC: C12N15/11
Filed: 2021-08-31
Abstract: Several embodiments disclosed herein relate to methods and compositions for enhanced expansion of NK cells in culture. In several embodiments, the methods utilize one or more soluble interleukins as culture media supplements at one or more time points during expansion of the NK cell, or other immune cell, the expansion employing a feeder cell population.
Patent AU-2021342424-A1 (AU)
Title: Delivery systems for cardiac valve devices, and associated methods of operation
Inventor: ZIMMERMAN NEIL
IPC: A61F2/24
Filed: 2021-09-15
Abstract: Delivery systems for implanting cardiac valve repair devices are disclosed herein. In some embodiments, a delivery system includes a delivery catheter, a hub shaft extending through the delivery catheter, and a core shaft extending through the hub shaft. The delivery catheter is configured to hold a valve repair device in a compressed configuration. The hub shaft includes a hub configured to releasably engage a first portion of the valve repair device, and the core shaft includes a plug configured to releasably engage a second portion of the valve repair device. When the valve repair device is unsheathed from the delivery catheter, the hub shaft and the core shaft are independently movable to axially elongate/compress the valve repair device. When the valve repair device is properly positioned, the hub can be actuated to release the first portion of the valve repair device, and the plug can be actuated to release the second portion of the valve repair device.
Patent AU-2021351255-A1 (AU)
Title: Sars-cov-2 protein-derived peptide and vaccine containing same
Inventor: KIYOTANI KAZUMA
IPC: A61P31/14
Filed: 2021-04-30
Abstract: The present invention provides a SARS-CoV-2 protein-derived epitope peptide capable of inducing cytotoxic T cells. The present invention also provides: a polynucleotide encoding the peptide; an antigen-presenting cell presenting the peptide; a cytotoxic T cell (CTL) targeting the peptide; and a method for inducing the antigen-presenting cell or the CTL. The present invention further provides a composition or a pharmaceutical composition containing the foregoing as an active ingredient. Furthermore, the present invention provides a method for treating and/or preventing the corona virus infectious disease, and/or a method for suppressing the aggravation of the disease, using the peptide, the polynucleotide, the antigen-presenting cells, the cytotoxic T cells, or the pharmaceutical composition according to the present invention. Also provided is a method for an inducing an immune response to coronavirus infection.
Patent AU-2021379123-A1 (AU)
Title: Radiotherapy template assembly
Inventor: MAGEN OFER
IPC: A61B17/34
Filed: 2021-10-27
Abstract: A template assembly including a first grid (22) for placement on a first side of a body organ, defining a plurality of apertures (329) adapted to receive elongate applicators (410), a second grid (24) for placement on a second side of a body organ, defining a plurality of apertures (34), adapted to receive applicators passing through apertures of the first grid and the body organ and at least one frame (26) defining a large hole (72), positioned between the first and second grids and configured to grasp the body organ.
Patent AU-2021410773-A1 (AU)
Title: Method, apparatus and system for recovering a sailing vessel
Inventor: TODTER CHRIS
IPC: G05D1/08
Filed: 2021-12-22
Abstract: A self-righting sailing vessel is described. The self-righting sailing vessel may determine the occurrence of several predetermined events, such as the self-righting sailing vessel capsizing, present or imminent inclement weather, and/or a present or imminent vessel or large marine animal. Upon detection of one of these events, the self-righting sailing vessel causes at least its hull to become partially or completely submerged beneath the water. The self-righting sailing vessel is configured such that its rig is more buoyant than the rest of the vessel when the vessel is completely submerged beneath the water, causing the vessel to move towards an upright position while underwater. When the vessel is pointing towards an upright position, the vessel may begin ascending until it surfaces and is ready to continue sailing on top of the water.
Patent AU-2021440288-A1 (AU)
Title: ENZYME COMPOSITION FOR PREPARING β-NICOTINAMIDE MONONUCLEOTIDE, AND APPLICATION THEREOF
Inventor: YU TIEMEI
IPC: C12P19/30
Filed: 2021-09-13
Abstract: The present invention relates to the field of biotechnologies. Disclosed are an enzyme composition for preparing β-nicotinamide mononucleotide (NMN), and an application thereof. In the present invention, by using adenosine and nicotinamide as raw materials, D-ribose 1-phosphate and a nicotinamide ribose intermediate are generated under enzyme catalysis of an enzyme composition of a PNP enzyme and an NRK enzyme, and finally NMN is obtained; only two enzymes need to be involved in the whole reaction system, and the by-product adenine can be recycled. Moreover, only one molecule of ATP needs to be consumed for generating one molecule of NMN, thereby greatly reducing the process cost. The reaction of synthesizing NMN by NRK enzyme catalysis in the last step is irreversible, and thus, the substrate conversion rate can be greatly improved and the production cost can be further reduced.
Patent WO-2022246512-A1 (WO)
Inventor: RAWSON-HARRIS DOUGLAS
IPC: B60R9/058
Filed: 2022-05-26
Abstract: A removeable rack system (1) for a vehicle comprises a rigid rack member (3) configured to support a load on the vehicle and a fastening assembly (11) to removably fasten the rigid rack member to the vehicle surface. The rigid rack member (3) has foot members (4) to engage a vehicle surface and post members (6) at opposite ends (7a, 7b). The fastening assembly (11) comprises a flexible strap (12a) engageable with the rigid rack member (3) and a tensioning device (15) engageable with the flexible strap (12a) to apply a tensioning force on the strap. The flexible strap (12a) engages with and fastens the rigid rack member (3) to the vehicle in response to the tensioning force. The removable rack system (1) enables quick and convenient installation of a roof rack that can be removed without damaging the vehicle surface.
Patent AU-2022201153-A1 (AU)
Title: Methods and compositions for detecting esophageal neoplasias and/or metaplasias in the esophagus
Inventor: MARKOWITZ SANFORD D
IPC: G01N33/574
Filed: 2022-02-21
Abstract: The disclosure provides methods for identifying genomic loci that are differentially 
methylated in neoplastic cancers, e.g., esophageal cancers. Identification of methylated 
genomic loci, and optionally in combination with the identification of somatic mutations 
5 in TP53, has numerous uses, including for example, to characterize disease risk, to predict 
responsiveness to therapy, to non-invasively diagnose subjects and to treat subjects 
determined to have gastrointestinal neoplasias.
Patent AU-2022202424-A1 (AU)
Title: Color and lighting adjustment for immersive content production system
Inventor: JUTAN MICHAEL
IPC: G06T15/50
Filed: 2022-04-12
Abstract: In at least one embodiment, an immersive content generation system may receive a first input 
from a user indicating a lighting value. The computing device may receive a second input 
indicating a region of an immersive virtual environment to which the lighting value is to be 
applied. The computing device may apply the lighting value to the region of the immersive 
virtual environment. The computing device may output one or more images of the immersive 
virtual environment, the one or more images based, in part, on the input lighting value.  
Numerous other aspects are described.
Sheet 4/31 
N co~ 
coo 
coo 
~C) 
_N.. ... ... ............................  
0 
..-.r
.. ......... l ...t ... .........  
0.......... .
Patent AU-2022203459-A1 (AU)
Title: Modular power and/or data system
Inventor: ELLIOTT GARTH
IPC: H02G3/08
Filed: 2022-05-20
Abstract: Disclosed herein is a modular power and/or data system 100 for mounting to a substrate 200.  
System 100 comprises a housing 110 for connection to rear surface 204 of substrate 200.  
Housing 110 comprises a base 112, a top 114 spaced from the base, and sidewalls 116 extending 
between the base 112 and the top 114. Top 114 has a peripheral flange 114a extending outwardly 
from sidewalls 116 and having openings 114b therein to receive fasteners 300 for connecting 
housing 110 to rear surface 204 of substrate 200. Base 112 and sidewalls 116 define an interior 
volume 117 of the housing 110, and top 114 defines an opening 118 into the interior volume 117.  
A frame 120 for mounting at least one electrical power or data port 130 in the opening 206 of the 
substrate 200 is connected relative to the housing 110. The relative connection between housing 
110 and frame 120 permits adjustment of a spacing S between housing base 112 and frame 120.
1/5 
152 100 
160FG 1 
150 
130 160 
206 
202 
140
200 
110 
FIG. 1
Patent AU-2022204246-A1 (AU)
Title: Capsid-modified, raav3 vector compositions and uses in gene therapy of human liver cancer
Inventor: SRIVASTAVA ARUN
IPC: A61P35/00
Filed: 2022-06-17
Abstract: Disclosed are next-generation multi-mutated modified capsid protein-modified expression vectors (rAAV 
particles), as well as infectious virions, compositions, and pharmaceutical formulations that include them.  
Also disclosed are methods of preparing and using these high transduction efficiency vector constructs in a 
variety of therapeutic applications including, inter alia, as delivery agents for the treatment amelioration of 
one or more diseases or abnormal conditions in an affected mammal using in-vivo and/or ex situ viral 
vector-based gene therapy protocols. Also disclosed are large-scale production methods for the multi
mutated, capsid-modified expression vectors, viral particles, and infectious virions, as well as use of the 
disclosed compositions in the manufacture of medicaments for use in a variety of in-vitro and/or in-vivo 
therapeutic methodologies.
Patent AU-2022204856-A1 (AU)
Title: Modular implant position manipulator system
Inventor: KAUFMANN CHRISTOPHER
IPC: A61N1/05
Filed: 2022-07-06
Abstract: This document discusses, among other things, systems and methods for 
device-assisted manipulation of an implant's position in a patient, such as for 
delivering and positioning a cochlear implant. An exemplary modular system 
5 includes an implant position manipulator (IPM) unit reversibly engaging an 
elongate member of an implant, and a user control device for applying driving 
force to the IPM unit to regulate the motion of the implant. The system may 
include sensors providing feedback on the position or the motion of the implant, 
or the force or friction applied to the implant during the implantation procedure.
Patent AU-2022207356-A1 (AU)
Title: System and method for enabling exchange of online bets
Inventor: GORDON RYAN
IPC: G06Q50/34
Filed: 2022-01-12
Abstract: The present invention provides a computer-implemented method of exchanging online bets, the method including: receiving, by one or more processors, bet data relating to an online bet placed by a gambler in relation to a gambling event, the bet data including a purchase price and initial odds associated with the bet at the time the bet was purchased, the bet including an initial value according to the purchase price and initial odds; causing, by the one or more processors, a data communication device associated with the gambler to display a cash out prompt in relation to the bet; receiving, by the one or more processors, from the gambler data communication device, a response to the cash out prompt confirming that the gambler prefers to consider a cash out of the online bet value according to a current value of the bet according to the current odds as compared with the initial odds; causing, by the one or more processors, a data communication device associated with one or more other entities to display the bet data, the current odds, and a purchase prompt; receiving, by the one or more processors, from a data communication device associated with the one or more other entities, a response to the purchase prompt, the response including a purchase proposal; causing, by the one or more processors, the data communication device associated with the gambler to display the purchase proposal; and in the event the gambler accepts the purchase proposal, performing, by the one or more processors, one or more actions to initiate a transfer of ownership of the bet from the gambler to the purchasing entity substantially in real-time.
Patent AU-2022209203-A1 (AU)
Title: Anti-NTB-A antibodies and related compositions and methods
Inventor: LEWIS TIMOTHY
IPC: A61P35/00
Filed: 2022-07-25
Abstract: ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND 
METHODS 
ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS 
ABSTRACT 
Disclosed are antibodies, including antibody drug conjugates, that specifically bind to NTB-A. Also 
disclosed are methods for using the anti-NTB-A antibodies to detect or modulate activity of (e.g., inhibit 
proliferation of) an NTB-A-expressing cell, as well as for diagnoses or treatment of diseases or disorders 
(e.g., cancer) associated with NTB-A-expressing cells, such as multiple myloma, non-Hodgkin 
lymphoma and acute myeloid leukemia.
Patent AU-2022216288-A1 (AU)
Title: Baluster connectors and systems having the same
Inventor: BARNDS PATRICK MICHAEL
IPC: E04F11/00
Filed: 2022-02-04
Abstract: Baluster connectors and railing systems utilizing baluster connectors. The baluster connectors can include a baluster engaging portion, a support engaging portion, and a flange.
Patent AU-2022236947-A1 (AU)
Title: Functionalized cellulose, method of enzymatic functionalization of cellulose, process of enzymatic functionalization of cellulose using an organic acid and process for the production of a cellulose with increased hydrophobicity and article
Inventor: SIQUEIRA GERMANO
IPC: C08B15/00
Filed: 2022-03-18
Abstract: The present invention relates to a functionalized cellulose, in which the cellulose comprises hydrophobic ester groups from fatty acids, and also to processes and methods for functionalizing cellulose that produce cellulose with increased hydrophobicity.
Patent AU-2022257118-A1 (AU)
Title: Kappa-opioid receptor agonist implants for treatment of pruritus
Inventor: BEEBE DEVARNEY KATHERINE
IPC: A61K38/07
Filed: 2022-04-14
Abstract: The present disclosure provides compositions, methods and kits for treatment of pruritus (itch) in an individual. The compositions, methods, and kits are for administering an implant comprising a kappa-opioid receptor agonist to an individual, where the implant comprises a sustained release composition comprising a kappa-opioid receptor agonist and a biocompatible polymeric matrix. Implantation of the device allows a controlled release of kappa-opioid receptor agonist for an extended period of time. The implant may be implanted subcutaneously in an individual in need of continuous treatment with a kappa-opioid receptor agonist for treatment and relief of pruritus.
Patent AU-2022287200-A1 (AU)
Title: Method for producing casein and uses thereof
Inventor: CHAYOT ROMAIN
IPC: A23C19/02
Filed: 2022-05-31
Abstract: The invention relates to new methods for producing casein compositions by increasing casein ratio in compositions through heating of the composition, and uses thereof, in particular for producing cheese substitute.
Patent AU-2022292905-A1 (AU)
Title: Compositions comprising curcuminoids for use in the treatment of muscle soreness
Inventor: LAVAL JULIE
IPC: A61K31/12
Filed: 2022-06-15
Abstract: The present invention relates to the use of an improved curcuminoids composition for improving and/or maintaining functional performance and/or relieving, treating, decreasing and/or preventing muscle soreness in a subject during and/or after exercise.
Patent AU-2022317127-A1 (AU)
Title: Modified t cell receptors for the prevention and treatment of viral infections and cancer
Inventor: OLSON CLIFFORD
IPC: C07K14/725
Filed: 2022-07-27
Abstract: Modified T cell receptors, cells comprising the modified T cell receptors, nucleic acids encoding the modified T cell receptors, and methods for using the modified T cell receptors are contemplated. Modified T cell receptor comprising two peptide chains are disclosed herein. The two peptide chains may be the same or different, and each peptide chain comprises an extracellular domain comprising a variable region, a constant region, and a connecting peptide, a transmembrane domain, and an intracellular domain comprising a CD28 region and a CD3 ζ ITAM region. Nucleic acids encoding the modified T cell receptors, and vectors comprising the nucleic acids are also disclosed. Additionally, a method for treating cancer and/or a viral infection is disclosed comprising administering a cell comprising the modified T cell receptor.
Patent AU-2023200067-A1 (AU)
Title: Systems and methods for smartcard biometric enrollment
Inventor: BHATT SUMEET
IPC: G06F21/62
Filed: 2023-01-05
Abstract: Systems, methods, and non-transitory computer readable media relate to 
smartcard biometric enrollment. In an embodiment that does not require a user to visit a 
central location to provide fingerprint images, an activation code corresponding to a unique ID 
5 that uniquely identifies a user of a service is generated and sent to the user. In response, at 
least one finger image is received from a user device. The image is processed to isolate a 
fingerprint image, which is used to generate a biometric template that is sent to a smartcard 
manufacturer and used to configure a smartcard for biometric authentication of the user. In 
another embodiment, a kiosk/ATM provides smartcard biometric enrollment by detecting a 
10 smartcard in the smartcard reader, verifying an ID of a user associated with the smartcard, 
capturing a biometric image from the user, processing the biometric image to generate a 
biometric template, and storing the biometric template on the smartcard.  
20
Patent AU-2023203727-A1 (AU)
Title: Biologically relevant orthogonal cytokine/receptor pairs
Inventor: GARCIA KENAN CHRISTOPHER
IPC: A61K48/00
Filed: 2023-06-15
Abstract: Engineered orthogonal cytokine receptor/ligand pairs, and methods of use thereof, are 
provided.
Patent AU-2023229560-A1 (AU)
Title: Floating offshore structures with round pontoons
Inventor: SOUZA MARCELO I L
IPC: B63B35/44
Filed: 2023-09-14
Abstract: A floating offshore structure includes a buoyant hull including a first column, a 
second column, and a pontoon coupled to the first column and the second column.  
Each column is vertically oriented and the pontoon extends horizontally from the first 
column to the second column. Each column has a central axis, an upper end, and a 
lower end. The pontoon includes a first tubular member and a second tubular member 
positioned laterally adjacent to the first tubular member. Each tubular member has a 
central axis, a first end coupled to the lower end of the first column, and a second end 
coupled to the lower end of the second column. The longitudinal axis of the first tubular 
member and the longitudinal axis of the second tubular member are disposed in a 
common horizontal plane.
Patent AU-2023254863-A1 (AU)
Title: ELP fusion proteins for controlled and sustained release
Inventor: JOWETT JAMES
IPC: A61K38/00
Filed: 2023-10-23
Abstract: The present disclosure provides pharmaceutical formulations for sustained release, and methods for 
delivering a treatment regimen with a combination of sustained release and long half-life formulations. The 
disclosure provides improved pharmacokinetics for peptide drugs.
WO 2017/192449 PCT/US2017/030403 
....... ...... ........ ...... ...... ... ...... .. ...... r 
... ......  
....b....  
ct~ 
...........  
0 
-~1/9
Patent AU-2024200012-A1 (AU)
Title: Repeated administration of non-immunosuppressive antigen-specific immunotherapeutics
Inventor: MALDONADO ROBERTO A
IPC: A61K31/436
Filed: 2024-01-02
Abstract: This invention relates to repeated administration of antigen-specific immunotherapeutics 
using protocols, or elements thereof, that do not induce immunosuppression. In some 
embodiments, the protocol has been previously shown not to induce immunosuppression in a 
subject.
Patent WO-2012174616-A1 (WO)
Title: Porous magnetic sorbent
Inventor: MAGERRAMOV ABEL MAMEDALI
IPC: B01J20/02
Filed: 2011-06-21
Abstract: The invention relates to the field of producing polymer sorbents having magnetic properties, and can be used for removing petroleum products from a water surface. A magnetic porous sorbent for removing thin petroleum films from a water surface is proposed, said sorbent being produced on the basis of industrial synthetic butadiene rubber SBR, as a result of the modification thereof by an oxidative chlorophosphorylation reaction with subsequent immobilization of magnetite  Fe 3 О 4 
  nanoparticles; and a method for producing a magnetic material is proposed, said method comprising the formation of  Fe 3 О 4 
  nanoparticles by an ion deposition method directly within a porous polymer matrix. The sorbent has a good sorption capacity in relation to thin petroleum films.
Patent WO-2012100306-A1 (WO)
Title: Procédé et appareil destinés à la commande et surveillance d'un distributeur automatique
Inventor: FELIQUE PASCAL
IPC: G07F9/02
Filed: 2011-01-28
Abstract: La présente invention concerne une solution comprenant des procédés et des techniques économiques permettant d'ajouter une API de distribution standard à un distributeur automatique traditionnel, de commander et surveiller le distributeur automatique durant son fonctionnement normal, sans changer la carte originale Contrôleur de distributeur automatique (VMC). Un aspect clé de la présente invention est l'implémentation d'une API de distribution standard au moyen d'un protocole de communication de données propriétaire par le biais d'une connexion de réseau entre un dispositif de lecture multimédia de consommateur et un microcontrôleur supplémentaire du distributeur automatique. La présente invention concerne des procédés d'interfaçage et un protocole de communication entre un dispositif de lecture multimédia de consommateur, un microcontrôleur et un contrôleur de distributeur automatique. Le microcontrôleur implémente une couche d'abstraction de matériel servant à cacher le matériel de distribution sous-jacent au dispositif de lecture multimédia du consommateur. Le dispositif de lecture multimédia du consommateur peut exécuter une application qui utilise l'API de distribution standard afin de commander et surveiller le distributeur automatique durant son fonctionnement normal, et peut transformer un distributeur automatique traditionnel en un distributeur automatique doté d'une interface utilisateur graphique, de capacités de publicité multimédia et de kiosque d'informations. Les procédés et les techniques selon l'invention peuvent être intégrés dans un dispositif périphérique MDB esclave d'un distributeur automatique.